Comparison

Acrivastine European Partner

Manufacturer MedChem Express
Category
Type Inhibitors
Specific against other
Amount 50 mg
Item no. HY-B1510-50mg
CASRN 87848-99-5
eClass 6.1 30220300
eClass 9.0 32160605
Available
Product Description
Acrivastine (BW825C) is a short acting histamine 1 receptor antagonist for the treatment of allergic rhinitis.
StorageTemperature
-20°C, 3 years; 4°C, 2 years (Powder)
Shipping
Room Temperature
Manufacturers Applications
COVID-19-immunoregulation
MolecularWeight
348.44
Clinical_Information
Launched
Manufacturers Research_Area
Inflammation/Immunology; Endocrinology
Solubility
DMSO : 50 mg/mL (ultrasonic)|H2O : 1 mg/mL (ultrasonic; warming; heat to 80°C)
Manufacturers Target
Histamine Receptor
Pathway
GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close